Therapeutic target
Breakthrough of laryngospasm.
Therapy recommendations
- In cases of persistent (“not subsiding”) laryngospasm, administration of agents (e.g., propofol) for induction of anesthesia (induction of anesthesia)
- Injection of botulinum toxin; therapy of choice for spasmodic dysphonia (speech spasm) and laryngospasm.
